Jorveza Европейский союз - английский - EMA (European Medicines Agency)

jorveza

dr. falk pharma gmbh - budesonide - esophageal diseases - antidiarrheals, intestinal antiinflammatory / antiinfective agents - jorveza is indicated for the treatment of eosinophilic esophagitis (eoe) in adults (older than 18 years of age).

JORVEZA 0.5 MG Израиль - английский - Ministry of Health

jorveza 0.5 mg

rafa laboratories ltd - budesonide - tablets orodispersible - budesonide 0.5 mg - budesonide - treatment of eosinophilic esophagitis (eoe) in adults.

JORVEZA 1 MG Израиль - английский - Ministry of Health

jorveza 1 mg

rafa laboratories ltd - budesonide - tablets orodispersible - budesonide 1 mg - budesonide - treatment of eosinophilic esophagitis (eoe) in adults.

FASENRA Израиль - английский - Ministry of Health

fasenra

astrazeneca (israel) ltd - benralizumab - solution for injection - benralizumab 30 mg / 1 ml - benralizumab - fasenra is indicated as an add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists.